Contact
Please use this form to send email to PR contact of this press release:
Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application
TO:
Please use this form to send email to PR contact of this press release:
Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application
TO: